Comment on Jaki et al., A proposal for a new PhD level curriculum on quantitative methods for drug development. Pharmaceutical Statistics 17 (5):593-606, Sep/Oct 2018, DOI: 10.1002/pst.1873

Affiliations

• ¹ Clinical Pharmacology, Idorsia Pharmaceuticals Ltd, Allschwil, Switzerland.
• ² Department of Clinical Pharmacy and Biochemistry, Institute of Pharmacy, Freie Universität Berlin, Germany.
• ³ Computational Physiology, Institute of Mathematics, University of Potsdam, Germany.
• ⁴ Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden.
• ⁵ Quantitative Sciences, Janssen Pharmaceutical Companies of Johnson and Johnson, Titusville, New Jersey.
• ⁶ Department of Pharmaceutical Sciences, School of Pharmacy, State University of New York at Buffalo, New York.
• ⁷ Computational and Data Enabled Science and Engineering Program, University at Buffalo, New York.
• ⁸ Statistical Modeling and Data Sciences, Metrum Research Group, Tariffvile, Connecticut.
• ⁹ IAME, UMR1137, Inserm and Université de Paris Diderot, Paris, France.
• ¹⁰ Biostatistics and Data Management, Regeneron Pharmaceuticals, Inc., Tarrytown, New York.